Skip to main content
logo
Nxera Pharma Co., Ltd. (SOLTF)
OTCMKTS · Delayed Price · Currency is USD
6.25
0.00 (0.00%)
Aug 26, 2025, 8:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Pharmaceutical
28.84B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
125.87%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Japan
14.06B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
127.73%
Log In
Log In
Log In
Log In
Upgrade
United States
7.95B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
479.02%
Log In
Log In
Log In
Log In
Upgrade
Germany
2.78B
Log In
Log In
Log In
Log In
Upgrade
Switzerland
2.19B
Log In
Log In
Log In
Log In
Upgrade
Switzerland Growth
-45.30%
Log In
Log In
Log In
Log In
Upgrade
Bermuda
1.16B
Log In
Log In
Log In
Log In
Upgrade
Bermuda Growth
-4.29%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
696.00M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
17300.00%
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
-
Log In
Log In
Log In
Log In
Upgrade